Patients in the anti-Xa HA group also had more test values within the therapeutic range (66% vs 42%, p < 0.0001). A significant difference was seen between the 2 groups in the number of aPTT or ...
[34] The principal secondary outcome was the percentage of monitoring test results below, within, and above the therapeutic range. These variables were collected to assess the ability of aPTT- and ...